Publicaciones en las que colabora con Santiago Moreno Guillén (63)

2024

  1. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

    Journal of Fungi, Vol. 10, Núm. 3

2023

  1. Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection

    Journal of Fungi, Vol. 9, Núm. 2

2022

  1. Carbapenemase-producing Enterobacterales infections in COVID-19 patients

    Infectious Diseases, Vol. 54, Núm. 1, pp. 36-45

2021

  1. COVID-19 and geographical area of origin

    Clinical Microbiology and Infection, Vol. 27, Núm. 4, pp. 632.e1-632.e5

  2. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

2020

  1. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

    The Lancet HIV, Vol. 7, Núm. 8, pp. e554-e564

  2. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

    International Journal of Infectious Diseases, Vol. 101, pp. 24-28

  3. Roles of the multiplex real-time PCR assay and β-D-glucan in a high-risk population for intra-abdominal candidiasis (IAC)

    Medical mycology, Vol. 58, Núm. 6, pp. 789-796

2019

  1. Aerosolized lipid amphotericin b for complementary therapy and/or secondary prophylaxis in patients with invasive pulmonary aspergillosis: A single-center experience

    Mycopathologia, Vol. 184, Núm. 2, pp. 239-250

2018

  1. Changes in tuberculosis in human immunodeficiency virus infected patients in a Spanish tertiary hospital (1995-2013)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 4, pp. 329-335

  2. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  3. T2 magnetic resonance for the diagnosis of deep-seated invasive candidiasis in a liver recipient without candidemia

    Revista Iberoamericana de Micologia, Vol. 35, Núm. 3, pp. 159-161

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

  2. The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013)

    Medicine (United States), Vol. 96, Núm. 26

2016

  1. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients

    Journal of Infection, Vol. 72, Núm. 6, pp. 738-744

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2014

  1. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3134-3141

  2. Extra-pulmonary tuberculosis: A biomarker analysis

    Infection, Vol. 42, Núm. 4, pp. 649-654

  3. Extra-pulmonary tuberculosis: Differential aspects and role of 16S-rRNA in urine

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 4, pp. 478-485